In terms of response to cancer therapy, the insulator protein CTCF mediated the down-regulation of telomerase in response to sulforaphane exposure, a compound that has histone deacetylase inhibition activity, in human breast cancer cells [32]. The gene discussed is CTCF; the disease is breast carcinoma.